UnitedHealth Group Surges as Q2 Results Exceed Expectations

UnitedHealth Group's latest Q2 results beat revenue and earnings expectations, sending fresh investor attention its way. Management raised full-year adjusted EPS guidance and highlighted tighter cost control across key healthcare segments.

The company's Q2 beat and higher full-year EPS guidance come after a mixed share price pattern. UnitedHealth Group is up 16.8% year to date but only saw a 1.5% total shareholder return over five years, suggesting long-term momentum has been muted.

Bulls point to the company's strong Q2 delivery and raised EPS guidance, while bears focus on sluggish five-year returns, regulatory scrutiny, and cost pressures.